deaths (OS)

mML - L2 - all population metastatic/adv melanoma (mML) mML - 2nd line (L2) mML - L2 - all population

versus Standard of Care (SoC)
nivolumab alone vs. Standard of Care (SoC) 1 0.95 [0.73; 1.24], 1 RCT, I2=0%
inconclusive result